Last reviewed: June 6, 2026
Last updated: June 6, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Many people wonder whether they need to continue GLP-1 therapy like semaglutide once they reach their target weight. Clinical data shows that approximately 70% of weight returns within one year after stopping GLP-1 treatment, making the decision to continue or pause more nuanced than most expect. PlexusDx breaks down your real options and what the science actually tells us.
What Happens When You Stop Taking Semaglutide
Stopping semaglutide triggers a return of appetite signals your brain had suppressed during treatment. Within weeks, hunger hormones like ghrelin rise back to baseline levels, while satiety hormones drop. This biological shift explains why simply 'stopping when you hit your goal' frequently backfires—your body is actively working against weight maintenance.
Research from major clinical trials shows that participants who discontinued semaglutide regained 50% of lost weight within one year on average. Some studies report even steeper rebound when treatment stops abruptly. The weight-loss plateau you achieved does not automatically become your new 'set point'; instead, your appetite-control system reverts to its pre-treatment state, making continued hunger and overeating the default pathway.
Long-Term Weight Maintenance: The Evidence for Continued GLP-1 Therapy
Long-term clinical data supports ongoing GLP-1 use as the most reliable way to hold onto weight loss gains. Trials tracking participants for 2–3 years show that those who remain on semaglutide or tirzepatide maintain 80–90% of weight loss, while discontinuation groups lose those benefits rapidly. The STEP program, one of the largest semaglutide trials, demonstrated that treatment must continue to preserve results.
Weight regain is not a sign of personal failure or weak willpower—it is a predictable physiological response to stopping an appetite-suppressing medication. Your genetics, metabolic history, and hormone balance all play roles in how quickly rebound occurs. This is why PlexusDx emphasizes personalization: your genetic makeup, tested through the Precision Peptide Genetic Test, can reveal how strongly your GLP-1 and GIPR pathways respond, helping predict whether you are a candidate for dose adjustment or transition to maintenance dosing rather than full discontinuation.
Three Paths Forward After Reaching Your Weight Loss Goal
Option one is continuing your current dose indefinitely. This approach has the strongest evidence and is what most weight-loss specialists recommend for durable results. Your dose may have risen during the weight-loss phase, but PlexusDx's pricing model ensures your monthly cost stays the same—semaglutide injection starts at $149 per month flat, no matter whether you are on a maintenance microdose or a higher therapeutic dose.
Option two is transitioning to a lower maintenance dose. Some patients find success at a reduced frequency or lower weekly injection amount that suppresses appetite without the stronger side effects of higher dosing. This requires medical supervision and tracking to ensure you do not slip back into weight regain patterns. Option three involves attempting to sustain your weight through lifestyle alone, though clinical evidence shows this fails in the majority of cases without pharmaceutical support. Your PlexusDx provider can help you assess which path aligns with your health history, genetic predispositions, and long-term goals.
The Role of Genetics in Predicting Your Weight Rebound Risk
Your genetic variants in the GLP1R, GIPR, FTO, and MC4R genes influence how strongly you respond to semaglutide and how much of your weight you are likely to regain if you stop. PlexusDx's Precision Peptide Genetic Test maps 14 biological pathways and 49 peptides to reveal whether your genes favor sustained appetite suppression or pose a higher rebound risk. If your genetic profile shows strong FTO predisposition toward weight gain, for example, maintaining GLP-1 therapy becomes even more critical to your long-term success.
This test is available as a $99 add-on after your first month of treatment, giving you and your provider data-driven insight into whether you are genetically suited for a lower maintenance dose, full continuation, or a different compound altogether. Many patients discover they respond better to dual-compound options like GLP-Squared Injection (which combines semaglutide and tirzepatide) based on their peptide pathway results—a personalization choice that would be impossible without genetic testing.
Practical Cost and Access Considerations
PlexusDx makes long-term GLP-1 therapy affordable and accessible across all 50 states without insurance or membership fees. Compounded semaglutide injection costs $149 per month flat—your dose may rise or fall, but your price will not. If you later explore oral semaglutide ($249/mo) or other compounds, transparent flat pricing means you understand your investment upfront and can budget confidently for years ahead.
All medications come from licensed 503A compounding pharmacies, ensuring pharmaceutical quality without the premium brand-name markup. HSA and FSA accounts are eligible, reducing your true out-of-pocket cost significantly. For patients who struggle with injection anxiety, oral semaglutide and tirzepatide options are available at slightly higher monthly rates, enabling you to maintain treatment without the needle-phobia barrier that sometimes tempts people to quit prematurely.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
Can I stop semaglutide once I reach my goal weight without gaining it back?
Clinical data shows approximately 70% of weight returns within one year after stopping GLP-1 therapy. Most weight-loss specialists recommend continuing treatment at a maintenance dose to preserve results, since your body's appetite-control system reverts to its pre-treatment state once medication stops. PlexusDx providers can help you design a long-term plan that fits your goals.
What does the research say about weight rebound after stopping GLP-1?
The STEP trials and other major studies demonstrate that participants who discontinue semaglutide regain 50% or more of lost weight within 12 months, while those who continue maintenance therapy retain 80–90% of their loss. Weight regain is a predictable physiological response, not a personal failure, because your hunger hormones (ghrelin) spike and satiety signals (GLP-1 and peptide YY) drop when medication stops.
How much does it cost to stay on semaglutide long-term through PlexusDx?
PlexusDx compounded semaglutide injection starts at $149 per month flat—your dose may need to go up or down, but your price will not change. No insurance is required, no membership fee applies, and HSA/FSA accounts are eligible, making long-term therapy both transparent and budget-friendly.
Is a maintenance dose of semaglutide safe to use indefinitely?
Yes; clinical trials spanning 2–3 years show semaglutide is safe for extended use when monitored by a healthcare provider. Side effects typically diminish after the first few months, and maintenance dosing is often lower and better tolerated than the higher doses used during active weight loss. Regular check-ins with your PlexusDx provider ensure your dose remains appropriate.
How can the Precision Peptide Genetic Test help me decide whether to continue therapy?
The PlexusDx Precision Peptide Genetic Test analyzes variants in GLP1R, GIPR, FTO, and MC4R genes, revealing your genetic predisposition to appetite regulation and weight regain risk. If your profile shows strong weight-gain genetics (like FTO rs9939609), continuing GLP-1 therapy becomes even more important for long-term success. This $99 test is available after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Does Ozempic Help the Brain?
Why Is My Weight Loss So Slow on Semaglutide?